Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Incorporando nuevas evidencias sobre medicamentos inhalados en la EPOC. Asociación Latinoamericana de Tórax (ALAT) 2019
María Montes de Oca; Maria Victorina López Varela; Agustín Acuña; Eduardo Schiavi; Alejandro Casas; Antonio Tokumoto; Carlos A. Torres Duque; Alejandra Ramírez-Venegas; Gabriel García; Aquiles Camelier; Miguel Bergna; Mark Cohen; Efraín Sanchez-Angarita; Santiago Guzmán; Karen Czischke; Manuel Barros; Alejandra Rey;
Arch Bronconeumol. 2020;56:106-13
Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease
Javier de Miguel-Díez; Julio Núñez Villota; Salud Santos Pérez; Nicolás Manito Lorite; Bernardino Alcázar Navarrete; Juan Francisco Delgado Jiménez; Juan José Soler-Cataluña; Domingo Pascual Figal; Patricia Sobradillo Ecenarro; Juan José Gómez Doblas;
Arch Bronconeumol. 2024;60:226-37
Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit
Myriam Calle Rubio; Marc Miravitlles; José Luis López-Campos; Bernardino Alcázar Navarrete; Juan José Soler Cataluña; Manuel E. Fuentes Ferrer; Juan Luis Rodríguez Hermosa;
Arch Bronconeumol. 2023;59:725-35